|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Gene Mutations May Enable Targeted PSA Screening
Renal & Urology News
Men who have the BRCA2 gene mutation are significantly more likely than noncarriers to have intermediate- or high-risk prostate cancer found on prostate biopsy, according to the preliminary findings of an international study. The results support the use of targeted PSA screening for BRCA2 carriers, researchers concluded.
| Share this article:
'Road Map' Needed for Switch to Accountable Care
Policymakers need to launch a "Manhattan Project" to help healthcare providers transition to accountable care organizations and other alternative payment models, a health policy expert said.
Although hospitals, physicians and other healthcare providers understand the need to move away from fee-for-service, many are unsure of how to do it, are unable to do it or are trying to figure out how best to do it.
AUA Puts 2014 Residency Match Rate at 64 Percent
The American Urological Association announced the 2014 Urology Residency Match results, reporting that of medical students who submitted preference lists, 64 percent matched.
In total, results were issued to 446 students and 118 registered programs, according to the AUA.
Should Medical School Be Shortened to 3 Years? Some Programs Try Fast Tracking
The Washington Post
For Travis Hill, it was an offer too good to refuse. Last year when the 30-year-old neuroscientist was admitted to a new program at New York University School of Medicine that would allow him to complete medical school in only three years and guarantee him a spot in its neurosurgery residency, he seized it. Not only would Hill save about $70,000 — the cost of tuition and living expenses for the fourth year of medical school — he would also shave a year off the training that will consume the next decade of his life.
Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy
The New York Times
The prostate cancer drug Xtandi prolonged lives and delayed tumor progression when used before chemotherapy in a study of men with advanced cases of the disease, researchers said.
The study results are expected to open up a broader market for Xtandi, which was developed by Medivation and Astellas Pharma, and open a new front in its competition with Johnson & Johnson's blockbuster drug Zytiga.
Why Aren't Doctors More Tech-Savvy?
As written by Olga Khazan, "Whenever I feel like taking a trip back in time, I save myself the trouble of building a time machine and instead just head over to a doctor's office. For a millennial, or really anyone who lives a modern lifestyle, getting medical care is a rare departure from an otherwise technology-fueled existence."
Acentec Study Shows Affordable Care Act Not Always Beneficial to Independent Physicians
Acentec via PRWeb
While much of the buzz surrounding the Affordable Care Act has been focused around its benefits to patients, less attention has been given to how it affects physicians. Acentec Inc., a medical practice solution and service provider, recently released a survey showing that many independent physicians were not yet benefiting from the ACA, and that many were still in the dark as to how to take advantage of it.
Study Could Lead to 'Liquid Biopsy' Tests for Bladder Cancer
Loyola University Health System via ScienceDaily
Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.
Bladder cancer is the fourth most common nonskin cancer. But there is no good screening test for it, and there has been limited progress in characterizing how aggressive an individual's bladder cancer will be.
Little Threat to Specialists' Revenue in Choosing Wisely Recommendations
Treatment guidance from medical specialty groups varies widely in terms of its potential financial impact on providers, acknowledges the head of the American Board of Internal Medicine Foundation, which backs the Choosing Wisely initiative to promote evidence-based care. Most of the 60 physician societies and medical specialty groups participating in the American Board of Internal Medicine Foundation's Choosing Wisely campaign to curb unnecessary tests or treatments do not list high-revenue services, according to the New England Journal of Medicine.
Congress Poised to Change Medicare Payment Policy — What Does That Mean for Patients and Doctors?
Kaiser Health News
After years of legislative wrangling and last-minute patches, expectations are high among physician groups, lawmakers and Medicare beneficiaries that Congress could act this year to permanently replace the current Medicare physician payment formula. While committees in both chambers have approved their own "doc fix" proposals, the approaches have yet to be reconciled, and none have identified how they would pay for a repeal.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063